RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
ANI Pharmaceuticals - Stock

ANI Pharmaceuticals ROCE 2024

ANI Pharmaceuticals ROCE

0.11

Ticker

ANIP

ISIN

US00182C1036

WKN

A1W15D

In 2024, ANI Pharmaceuticals's return on capital employed (ROCE) was 0.11, a -220.66% increase from the -0.09 ROCE in the previous year.

ANI Pharmaceuticals Aktienanalyse

What does ANI Pharmaceuticals do?

The company ANI Pharmaceuticals Inc was founded in 2001 and is located in Baudette, Minnesota, USA. ANI Pharmaceuticals is a pharmaceutical company specialized in the development and manufacturing of generic, branded, and biosimilar drugs, as well as novel therapeutic products for a wide range of diseases. ANI Pharmaceuticals has earned a good reputation over the years as a reliable provider of medications for well-known medical conditions. The company specializes in the production of prescription drugs for various conditions, including central nervous system disorders, infectious diseases, cardiovascular diseases, pain, and attention deficit/hyperactivity disorders. ANI Pharmaceuticals' business model is to provide its customers with high-quality, cost-effective, and innovative drugs. The company has an extensive portfolio of products that includes both generics and branded drugs. The company has also specialized in the production of biosimilars - bioproducts that mimic biological drugs whose patent protection has expired. ANI Pharmaceuticals pursues a differentiation strategy to strengthen its competitive position through innovative products, brand building, quality control, and cost leadership. For example, in 2019, the company developed Exservan, a liquid treatment for amyotrophic lateral sclerosis (ALS) that patients can take daily through an enlarged mouth opening. ANI Pharmaceuticals has various business segments: - Generics Business: ANI Pharmaceuticals manufactures a variety of generics for various diseases, including drugs for Parkinson's disease, pain, hypertension, and antidepressants. - Branded Product Business: ANI Pharmaceuticals also markets its own portfolio of branded products, mainly based on critical medical needs. These include Inversine - an oral medication for hypertension, Lithium Carbonate - a medication for mood disorders, and Inderal - a medication for cardiovascular diseases. - Contract Manufacturing Business: ANI Pharmaceuticals also offers contract manufacturing services for other pharmaceutical companies. ANI Pharmaceuticals provides a range of development and manufacturing services, including process development, formulation development, scale-up, validation, packaging, and distribution. - Biosimilars Business: ANI Pharmaceuticals specializes in the production of biosimilars and is working on the development of biological replicas of drugs whose patent protection has expired. This allows patients to receive a more cost-effective alternative treatment. Overall, ANI Pharmaceuticals has a strong focus on manufacturing cost-effective and high-quality medications for patients and healthcare facilities. The company has an excellent product range and is well positioned to offer innovative and highly effective drugs for the treatment of diseases in the future. ANI Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling ANI Pharmaceuticals's Return on Capital Employed (ROCE)

ANI Pharmaceuticals's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing ANI Pharmaceuticals's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

ANI Pharmaceuticals's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in ANI Pharmaceuticals’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about ANI Pharmaceuticals Stock

What is the ROCE (Return on Capital Employed) of ANI Pharmaceuticals this year?

The ROCE of ANI Pharmaceuticals is 0.11 undefined this year.

How has the ROCE (Return on Capital Employed) of ANI Pharmaceuticals developed compared to the previous year?

The ROCE of ANI Pharmaceuticals has increased by -220.66% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of ANI Pharmaceuticals?

A high Return on Capital Employed (ROCE) indicates that ANI Pharmaceuticals has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of ANI Pharmaceuticals?

A low ROCE (Return on Capital Employed) can indicate that ANI Pharmaceuticals has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from ANI Pharmaceuticals impact the company?

An increase in the ROCE of ANI Pharmaceuticals can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of ANI Pharmaceuticals affect the company?

A decrease in ROCE of ANI Pharmaceuticals can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of ANI Pharmaceuticals?

Some factors that can affect ANI Pharmaceuticals's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of ANI Pharmaceuticals so important for investors?

The ROCE of ANI Pharmaceuticals is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can ANI Pharmaceuticals take to improve the ROCE?

To improve the ROCE, ANI Pharmaceuticals can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does ANI Pharmaceuticals pay?

Over the past 12 months, ANI Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, ANI Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of ANI Pharmaceuticals?

The current dividend yield of ANI Pharmaceuticals is .

When does ANI Pharmaceuticals pay dividends?

ANI Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of ANI Pharmaceuticals?

ANI Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of ANI Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is ANI Pharmaceuticals located?

ANI Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von ANI Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of ANI Pharmaceuticals from 7/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/1/2024.

When did ANI Pharmaceuticals pay the last dividend?

The last dividend was paid out on 7/1/2024.

What was the dividend of ANI Pharmaceuticals in the year 2023?

In the year 2023, ANI Pharmaceuticals distributed 0 USD as dividends.

In which currency does ANI Pharmaceuticals pay out the dividend?

The dividends of ANI Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The ANI Pharmaceuticals stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von ANI Pharmaceuticals

Our stock analysis for ANI Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ANI Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.